Case Studies
Featured
Merger debuts McDermott Will & Schulte, new legal powerhouse
Inside Day 1 at McDermott HealthEx: Strategic Insights from Healthcare Leaders
McDermott Expands in Dallas with Move to New Office Space
Economic Crime Act 'Only Moves the Dial from Impossible to Quite Difficult'
August 25, 2025
McDermott Will & Schulte hires veteran advisor Ira Schacter to lead new financial services vertical dedicated to serving clients operating in today’s financial ecosystem
August 6, 2025
McDermott adds cross-border asset recovery partner in San Diego
July 21, 2025
McDermott attracts elite private client talent with the addition of David Pratt
October 22, 2025
McDermott Advises Studio 100 International on Strategic Alliance with Animaj
McDermott Will & Schulte advises Cosmo5 on the acquisition of Storeis
McDermott advises Invesco Real Estate on strategic logistics joint venture with LCP
McDermott Will & Schulte advises Ardian Growth on its acquisition of a stake in JPB Système
McDermott Will & Schulte advises V-Bio Ventures on €38 million Series C financing of Step Pharma
October 20, 2025
Private Credit's Public Pivot – Crisis Play Or Permanent Shift?
October 17, 2025
Litigator of the week runners-up and shout-outs
McDermott Advises Rhein Invest on the Acquisition of a Majority Stake in MC Shape
October 16, 2025
McDermott represents GoodLeap in an innovative $183 million back-leverage securitization backed by GoodLeap-originated residential solar and battery storage customer agreements
Chambers UK 2026 rankings spotlight McDermott Will & Schulte’s expanding London strength
October 2025
2026 budget: Why the tax on holding companies is a ‘disguised’ return of the wealth tax for those affected
October 15, 2025
McDermott Will & Schulte advised EverZom on its €10 million financing round
McDermott Will & Schulte recognized once again for leadership in European restructuring by Turnarounds & Workouts
McDermott Will & Schulte’s health & life sciences group recognized by LMG Life Sciences 2025
Medicine prices in Europe could rise following Trump's pressure on pharmaceutical companies
October 14, 2025
McDermott represents Tether in strategic investment in Bit2Me
McDermott Advises Main Capital Partners on the Acquisition of OSSENO by its Portfolio Company PeakAvenue
September 1, 2025
Discussing the EU Data Act on NIKKEI NEWS NEXT